MOLINA HEALTHCARE INC (MOH) Stock Earnings & Estimates
USA - New York Stock Exchange - NYSE:MOH - US60855R1005 - Common Stock
181.5 USD
-2 (-1.09%)
180.46 USD
-1.04 (-0.57%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 31.974B 15.13% | 34.072B 6.56% | 40.65B 19.31% | 45.201B 11.20% | 47.131B 4.27% | 50.279B 6.68% | 51.817B 3.06% | 54.832B 5.82% | 59.651B 8.79% | 62.858B 5.38% | 66.238B 5.38% | 70.021B 5.71% | |
| EBITDA YoY % growth | 1.615B 29.61% | 1.785B 10.53% | 1.894B 6.11% | 1.307B -30.99% | 1.305B -0.15% | 1.407B 7.82% | N/A | 2.31B | 2.552B 10.48% | 2.77B 8.54% | 3.009B 8.63% | 3.221B 7.05% | |
| EBIT YoY % growth | 1.439B 29.06% | 1.614B 12.16% | 1.708B 5.82% | 1.068B -37.47% | 1.022B -4.31% | 1.224B 19.77% | 1.829B 49.43% | 1.864B 1.91% | 2.182B 17.06% | 2.384B 9.26% | 2.604B 9.23% | 2.798B 7.45% | |
| Operating Margin | 4.50% | 4.74% | 4.20% | 2.36% | 2.17% | 2.43% | 3.53% | 3.40% | 3.66% | 3.79% | 3.93% | 4.00% | |
| EPS YoY % growth | 17.91 32.18% | 20.89 16.64% | 22.65 8.43% | 14.40 -36.42% | 13.69 -4.95% | 16.32 19.23% | 24.96 52.92% | 28.97 16.07% | 33.51 15.69% | 37.54 12.03% | 43.20 15.07% | 46.60 7.88% |
All data in USD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.33 -93.48% | 4.54 -25.40% | 4.06 -25.88% | 2.90 57.47% | 2.06 524.75% | 5.17 13.90% | 4.69 15.51% | 3.78 30.30% | 3.04 47.64% |
| Revenue Q2Q % growth | 10.965B 4.44% | 11.673B 4.72% | 11.824B 3.47% | 11.954B 4.16% | 11.734B 7.01% | 12.45B 6.66% | 12.59B 6.48% | 12.747B 6.63% | 12.393B 5.62% |
| EBITDA Q2Q % growth | 101.36M -82.03% | 370.51M -23.29% | 349.53M -27.18% | 275.86M -4.22% | 216.7M 113.79% | 482.51M 30.23% | 389.19M 11.35% | 265.19M -3.87% | 209.48M -3.33% |
| EBIT Q2Q % growth | 43.152M -88.58% | 330.64M -23.99% | 298.22M -20.26% | 227.65M 66.17% | 157.75M 265.57% | 454.51M 37.46% | 361.55M 21.24% | 237.44M 4.30% | 182.45M 15.66% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 1.84 -69.38% | 3.94 | -2.10 | -53.34% |
| Q2 2025 Q2Q % growth | 5.48 -6.48% | 5.85 | -0.37 | -6.27% |
| Q1 2025 Q2Q % growth | 6.08 6.11% | 6.02 | 0.06 | 1.06% |
| Q4 2024 Q2Q % growth | 5.05 15.30% | 5.78 | -0.73 | -12.62% |
| Q3 2024 Q2Q % growth | 6.01 19.01% | 5.86 | 0.15 | 2.51% |
| Q2 2024 Q2Q % growth | 5.86 3.72% | 5.56 | 0.30 | 5.45% |
| Q1 2024 Q2Q % growth | 5.73 -1.38% | 5.64 | 0.09 | 1.51% |
| Q4 2023 Q2Q % growth | 4.38 6.83% | 4.39 | -0.01 | -0.33% |
| Q3 2023 Q2Q % growth | 5.05 15.83% | 4.93 | 0.12 | 2.44% |
| Q2 2023 Q2Q % growth | 5.65 24.18% | 5.15 | 0.50 | 9.76% |
| Q1 2023 Q2Q % growth | 5.81 18.57% | 5.17 | 0.64 | 12.27% |
| Q4 2022 Q2Q % growth | 4.10 42.36% | 4.06 | 0.04 | 1.07% |
| Q3 2022 Q2Q % growth | 4.36 54.06% | 4.25 | 0.11 | 2.53% |
| Q2 2022 Q2Q % growth | 4.55 33.82% | 4.34 | 0.21 | 4.90% |
| Q1 2022 Q2Q % growth | 4.90 10.36% | 4.71 | 0.19 | 4.14% |
| Q4 2021 Q2Q % growth | 2.88 664.71% | 2.78 | 0.10 | 3.75% |
| Q3 2021 Q2Q % growth | 2.83 -15.77% | 2.82 | 0.01 | 0.37% |
| Q2 2021 Q2Q % growth | 3.40 -29.02% | 3.41 | -0.01 | -0.30% |
| Q1 2021 Q2Q % growth | 4.44 47.02% | 3.72 | 0.72 | 19.46% |
| Q4 2020 Q2Q % growth | -0.51 | 0.90 | -1.41 | -156.91% |
| Q3 2020 Q2Q % growth | 3.36 | 2.19 | 1.17 | 53.16% |
| Q2 2020 Q2Q % growth | 4.79 | 4.77 | 0.02 | 0.33% |
| Q1 2020 Q2Q % growth | 3.02 | 2.97 | 0.05 | 1.53% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 11.477B 11.00% | 11.037B | 440M | 3.99% |
| Q2 2025 Q2Q % growth | 11.427B 15.66% | 11.063B | 364M | 3.29% |
| Q1 2025 Q2Q % growth | 11.147B 12.24% | 10.914B | 233M | 2.13% |
| Q4 2024 Q2Q % growth | 10.499B 16.04% | 10.427B | 72M | 0.69% |
| Q3 2024 Q2Q % growth | 10.34B 20.96% | 10.01B | 330M | 3.30% |
| Q2 2024 Q2Q % growth | 9.88B 18.65% | 9.844B | 36M | 0.37% |
| Q1 2024 Q2Q % growth | 9.931B 21.87% | 9.535B | 396M | 4.15% |
| Q4 2023 Q2Q % growth | 9.048B 10.03% | 8.452B | 596M | 7.05% |
| Q3 2023 Q2Q % growth | 8.548B 7.83% | 8.326B | 222M | 2.67% |
| Q2 2023 Q2Q % growth | 8.327B 3.39% | 8.4B | -73M | -0.87% |
| Q1 2023 Q2Q % growth | 8.149B 4.88% | 8.413B | -264M | -3.14% |
| Q4 2022 Q2Q % growth | 8.223B 10.99% | 7.95B | 273M | 3.43% |
| Q3 2022 Q2Q % growth | 7.927B 12.60% | 7.878B | 49M | 0.62% |
| Q2 2022 Q2Q % growth | 8.054B 18.44% | 7.765B | 289M | 3.72% |
| Q1 2022 Q2Q % growth | 7.77B 19.14% | 7.596B | 174M | 2.29% |
| Q4 2021 Q2Q % growth | 7.409B 41.53% | 7.262B | 147M | 2.02% |
| Q3 2021 Q2Q % growth | 7.04B 40.21% | 6.855B | 185M | 2.70% |
| Q2 2021 Q2Q % growth | 6.8B 47.25% | 6.443B | 357M | 5.54% |
| Q1 2021 Q2Q % growth | 6.522B 43.37% | 6.12B | 402M | 6.57% |
| Q4 2020 Q2Q % growth | 5.235B | 5.351B | -116M | -2.17% |
| Q3 2020 Q2Q % growth | 5.021B | 4.904B | 117M | 2.39% |
| Q2 2020 Q2Q % growth | 4.618B | 4.767B | -149M | -3.13% |
| Q1 2020 Q2Q % growth | 4.549B | 4.513B | 36M | 0.80% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -34.65% | -89.71% | -0.03% | -23.58% |
| Revenue | -0.04% | -0.89% | 0.06% | 0.73% |